Cargando…
Tamoxifen and bone morphogenic protein-7 modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats
BACKGROUND: Peritoneal fibrosis (PF) represents a long-term complication of peritoneal dialysis (PD), affecting peritoneal membrane (PM) integrity and function. Understanding the mechanisms underlying PF development in an uremic environment aiming alternative therapeutic strategies for treating this...
Autores principales: | Silva, Filipe M. O., Costalonga, Elerson C., Silva, Cleonice, Carreira, Ana C. O., Gomes, Samirah A., Sogayar, Mari C., Fanelli, Camilla, Noronha, Irene L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712623/ https://www.ncbi.nlm.nih.gov/pubmed/31455237 http://dx.doi.org/10.1186/s10020-019-0110-5 |
Ejemplares similares
-
Adipose-Derived Mesenchymal Stem Cells Modulate Fibrosis and Inflammation in the Peritoneal Fibrosis Model Developed in Uremic Rats
por: Costalonga, Elerson C., et al.
Publicado: (2020) -
Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis
por: Costalonga, Elerson C., et al.
Publicado: (2017) -
Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats
por: Silva, Filipe M. O., et al.
Publicado: (2022) -
Valproic Acid Prevents Renal Dysfunction and Inflammation in the Ischemia-Reperfusion Injury Model
por: Costalonga, Elerson C., et al.
Publicado: (2016) -
Tamoxifen exerts anti-peritoneal fibrosis effects by inhibiting H19-activated VEGFA transcription
por: Zhao, Tingting, et al.
Publicado: (2023)